Literature DB >> 26776589

Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy.

J R Payne1, K Borgeat2, D C Brodbelt1, D J Connolly1, V Luis Fuentes3.   

Abstract

OBJECTIVES: To evaluate risk factors associated with different types of cardiac death in cats with hypertrophic cardiomyopathy (HCM). ANIMALS: Two hundred fifty-five cats with HCM referred to a veterinary teaching hospital.
METHODS: This is a retrospective study. Cats with HCM were identified that had either died within 2 years of diagnosis or were known to be alive 2 years after initial examination. Signalment, physical exam, electrocardiographic and echocardiographic data were analyzed separately for association with death due to congestive heart failure (CHF) vs. aortic thromboembolism (ATE) vs. sudden death.
RESULTS: Within 2 years of follow-up, 23/255 (9.0%) cats had died with ATE, 44/255 (17.3%) cats had died with CHF and 12/255 (4.7%) cats had experienced a sudden death, with 141/255 (55.3%) cats still alive at the end of 2 years. Presence of CHF at presentation and reduced left ventricular fractional shortening (FS%) were independently associated with a CHF death within 2 years of diagnosis. Presence of ATE and reduced left atrial fractional shortening (LA-FS%) were independently associated with dying with ATE within 2 years. No multivariable models were generated for risks of dying a sudden death owing to the low event rate, but syncope at presentation and arrhythmias on auscultation were associated with sudden death on univariable analysis.
CONCLUSIONS: Asymptomatic cats have a reduced risk of all three types of death. Reduced FS% and a history of CHF independently predict CHF death, and reduced LA-FS% and history of ATE independently predict ATE death. Sudden death is less commonly reported but is associated with syncope.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATE; CHF; HCM; Left atrial function; Syncope

Mesh:

Year:  2015        PMID: 26776589     DOI: 10.1016/j.jvc.2015.09.008

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  29 in total

1.  Auriculectomy for spontaneous thrombosis of the left auricle in a domestic shorthair cat.

Authors:  Zachary Dvornicky-Raymond; Janis Lapsley; Valentin Janvier; Ileana Miranda; Sean McDonaugh; Galina Hayes
Journal:  Can Vet J       Date:  2020-08       Impact factor: 1.008

2.  Dual therapy with clopidogrel and rivaroxaban in cats with thromboembolic disease.

Authors:  Sara T Lo; Ashley L Walker; Catherine J Georges; Ronald Hl Li; Joshua A Stern
Journal:  J Feline Med Surg       Date:  2021-05-10       Impact factor: 2.015

3.  Distinctive egg-laying patterns in terminal versus non-terminal periods in three fruit fly species.

Authors:  Xiang Meng; Junjie Hu; Richard E Plant; Tim E Carpenter; James R Carey
Journal:  Exp Gerontol       Date:  2020-12-11       Impact factor: 4.032

4.  Immunohistological Evaluation of Von Willebrand Factor in the Left Atrial Endocardium and Atrial Thrombi from Cats with Cardiomyopathy.

Authors:  Wan-Ching Cheng; Lois Wilkie; Tsumugi Anne Kurosawa; Melanie Dobromylskyj; Simon Lawrence Priestnall; Virginia Luis Fuentes; David J Connolly
Journal:  Animals (Basel)       Date:  2021-04-26       Impact factor: 2.752

5.  Mitral Annular Plane Systolic Excursion and Tricuspid Annular Plane Systolic Excursion in Cats with Hypertrophic Cardiomyopathy.

Authors:  I Spalla; J R Payne; K Borgeat; A Pope; V Luis Fuentes; D J Connolly
Journal:  J Vet Intern Med       Date:  2017-03-30       Impact factor: 3.333

6.  International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.

Authors:  Philip R Fox; Bruce W Keene; Kenneth Lamb; Karsten A Schober; Valerie Chetboul; Virginia Luis Fuentes; Gerhard Wess; Jessie Rose Payne; Daniel F Hogan; Alison Motsinger-Reif; Jens Häggström; Emilie Trehiou-Sechi; Deborah M Fine-Ferreira; Reid K Nakamura; Pamela M Lee; Manreet K Singh; Wendy A Ware; Jonathan A Abbott; Geoffrey Culshaw; Sabine Riesen; Michele Borgarelli; Michael B Lesser; Nicole Van Israël; Etienne Côté; John E Rush; Barret Bulmer; Roberto A Santilli; Andrea C Vollmar; Maribeth J Bossbaly; Nadine Quick; Claudio Bussadori; Janice M Bright; Amara H Estrada; Dan G Ohad; Maria Josefa Fernández-Del Palacio; Jenifer Lunney Brayley; Denise S Schwartz; Christina M Bové; Sonya G Gordon; Seung Woo Jung; Paola Brambilla; N Sydney Moïse; Christopher D Stauthammer; Rebecca L Stepien; Cecilia Quintavalla; Christophe Amberger; Ferenc Manczur; Yong-Wei Hung; Remo Lobetti; Marie De Swarte; Alice Tamborini; Carmel T Mooney; Mark A Oyama; Andrey Komolov; Yoko Fujii; Romain Pariaut; Masami Uechi; Victoria Yukie Tachika Ohara
Journal:  J Vet Intern Med       Date:  2018-04-16       Impact factor: 3.333

7.  Detection of congestive heart failure by Doppler echocardiography in cats with hypertrophic cardiomyopathy.

Authors:  Michelle N Rohrbaugh; Karsten E Schober; Jaylyn D Rhinehart; John D Bonagura; Amy Habing; Vedat Yildiz
Journal:  J Vet Intern Med       Date:  2020-05-04       Impact factor: 3.333

8.  Speckle tracking echocardiography in cats with preclinical hypertrophic cardiomyopathy.

Authors:  Ilaria Spalla; Adrian Boswood; David J Connolly; Virginia Luis Fuentes
Journal:  J Vet Intern Med       Date:  2019-04-16       Impact factor: 3.333

9.  The use of focused cardiac ultrasound to screen for occult heart disease in asymptomatic cats.

Authors:  Kerry A Loughran; John E Rush; Elizabeth A Rozanski; Mark A Oyama; Éva Larouche-Lebel; Marc S Kraus
Journal:  J Vet Intern Med       Date:  2019-07-17       Impact factor: 3.333

10.  Layer-specific myocardial function in asymptomatic cats with obstructive hypertrophic cardiomyopathy assessed using 2-dimensional speckle-tracking echocardiography.

Authors:  Ryohei Suzuki; Yohei Mochizuki; Hiroki Yoshimatsu; Ayaka Niina; Takahiro Teshima; Hirotaka Matsumoto; Hidekazu Koyama
Journal:  J Vet Intern Med       Date:  2018-11-29       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.